0000000000114728

AUTHOR

G. Giannola

showing 5 related works from this author

Management of Atrial Fibrillation Suppression in AF-HF Comorbidity Therapy (MASCOT) Trial

2003

Inter- [1,2], intra- [3,4], and atrioventricular [51(AV) dyssynchrony are not new concepts, but only recently have attempts been made to correct these disorders in an effort to treat heart failure (HF). A series of trials [6] has addressed partial or comprehensive cardiac resynchronization in patients with severe HF and evidence of cardiac dyssynchrony. Cardiac resynchronization should improve left ventricular (LV) performance; several trials [7-10] have demonstrated improvement in many hemodynamic parameters (LV and aortic pressure, shortening of mitral diastolic regurgitation, synchronized LV and atrial systole, LV volume, reduced myocardial oxygen consumption) and clinical end-points (qu…

medicine.medical_specialtybusiness.industryDiastoleManagement of atrial fibrillationAtrial fibrillationmedicine.diseaseAsymptomaticFramingham Heart StudyHeart failureInternal medicineAortic pressurePhysical therapyCardiologyMedicinemedicine.symptomRisk factorbusiness
researchProduct

P-364 Effectiveness and safety of transvenous ICD leads extraction

2003

medicine.medical_specialtybusiness.industryPhysiology (medical)Extraction (chemistry)medicineCardiology and Cardiovascular MedicinebusinessSurgeryEP Europace
researchProduct

Can Ventricular Resynchronization Reduce Atrial Fibrillation Recurrences?

2003

In recent years a new pacing therapy has been proposed for patients affected by heart failure (HF) in order to reduce inter- [1,2], intra- [3,4], and atrioventricular [5] (AV) dyssynchrony. Cardiac resynchronization therapy (CRT) has the goal of correcting these hemodynamic disorders, thus improving left ventricular (LV) performance. The benefits of CRT have been evaluated in a series of clinical trials [6-10].

Atrial pacemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCardiac resynchronization therapyHemodynamicsAtrial fibrillationmedicine.diseaseSick sinus syndromeClinical trialHeart failureInternal medicinecardiovascular systemmedicineCardiologycardiovascular diseasesbusiness
researchProduct

Sleep Apnea: New Insights

2004

Sleep apnea is the most common disorder of breathing during sleep. It is defined as repeated episodes of obstructive apnea and hypopnea during sleep, together with daytime sleepiness or altered cardiopulmonary function [1]. There are three syndromes of upper airway closure during sleep: obstructive sleep apnea (OSA), obstructive sleep hypopnea, and upper airway resistance. These three syndromes share two features: excessive daytime sleepiness and arousal associated with increased ventilatory effort in response to upper airway closure. The specific sites of narrowing or closure and upper airway dysfunction are influenced by the underlying neuromuscular tone, upper airway muscle synchrony, an…

medicine.medical_specialtyCentral sleep apneabusiness.industrymedicine.medical_treatmentSleep apneaExcessive daytime sleepinessmedicine.diseaseSleep in non-human animalsrespiratory tract diseasesObstructive sleep apneaAirway resistanceInternal medicinemedicineCardiologyContinuous positive airway pressuremedicine.symptombusinessHypopnea
researchProduct

Elevated levels of lipoprotein (a) in patients suffering from myocardial infarction with carotid atherosclerotic lesions.

1999

The aim of the present study was to evaluate metabolic, coagulation and fibrinolytic parameters in 45 patients [31 men, 14 women, aged 56.5 +/- 3.5 years (mean +/- SD)] who had suffered myocardial infarction more than 6 months earlier, with or without carotid atherosclerotic lesions. After the extracranial carotid arteries had been evaluated using a B-mode Duplex scanning system, patients were subdivided into two groups: group 1 (n = 20) with carotid plaques or measurable intima-media thickness; and group 2 (n = 25) without carotid plaques or measurable intima-media thickness. Twenty-two age- and sex-matched subjects were recruited as controls (group 3). Groups 1 and 2 displayed significant…

Carotid Artery DiseasesMalemedicine.medical_specialtyArteriosclerosismedicine.medical_treatmentLipoproteinsMyocardial InfarctionFibrinogenBody Mass IndexRisk FactorsInternal medicineFibrinolysismedicineHumansMyocardial infarctionBlood CoagulationTriglyceridesbiologybusiness.industryFibrinolysisHematologyGeneral MedicineLipoprotein(a)Middle Agedmedicine.diseaseEndocrinologyApolipoproteinsCholesterolbiology.proteinCardiologyApolipoprotein A1FemalebusinessPlasminogen activatorProtein CBiomarkersLipoproteinmedicine.drugLipoprotein(a)Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct